Vi har träffat Medivirs vd Uli Hacksell som svarar på våra frågor om Q2-rapporten och pågående aktiviteter för att finna partners. Han går även igenom

Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors.

Medivirs verkställande direktör Yilmaz Mahshid har idag Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk kemi som en gång drömde om en karriär som sjukhusapotekare. på Pareto Securities och på Öhman Fondkommission. Nuvarande vd Uli Hacksell kommer därefter att kvarstå som styrelseledamot i bolaget. Active Biotech / Uli Hacksell / Uli Hacksell. 2021-03-23 09:48.

Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and 23 Feb 2020 Even if it's not a huge purchase, we think it was good to see that Uli Hacksell, the CEO, President & Director of 11 Mar 2015 The bio-pharmaceutical company announced Wednesday afternoon that Uli Hacksell retired as both its CEO and a member of its board of 7 apr 2021 STOCKHOLM (Nyhetsbyrån Direkt) Valberedningen i forskningsbolaget Annexin Pharmaceuticals föreslår att Uli Hacksell väljs in i styrelsen Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors. June 29, 2018 09:15 ET | Source: Marina Biotech, Inc. Marina Biotech, Ali Tabatabaei, Robert E. Davis, Mark R. Brann, Uli Hacksell and Douglas W. Bonhaus. Journal of Pharmacology and Experimental Therapeutics August 2007 2 Apr 2017 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 million , compared to the $1.1 million package received by Cerecor's 20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk kemi som en gång drömde om en karriär som sjukhusapotekare. 18 Aug 2020 Uli Hacksell, who has been CEO since October 2018, will remain as a Board Member of Medivir. Yilmaz Mahshid joins Medivir from his recent 9 Jul 2015 Uli Hacksell has over 20 years of international management experience from both large pharmaceutical and biotech companies.

BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

Uli Hacksell Ph.D. BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D.

2021-03-16, Uli Hacksell, Styrelseledamot, Eget, Förvärv, MVIR AB B, 52000, Antal, 8,78 SEK 2020-02-19, Uli Hacksell, VD, Eget, Förvärv, Medivir AB ser.

Journal of Pharmacology and Experimental Therapeutics August 2007 2 Apr 2017 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 million , compared to the $1.1 million package received by Cerecor's 20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk kemi som en gång drömde om en karriär som sjukhusapotekare. 18 Aug 2020 Uli Hacksell, who has been CEO since October 2018, will remain as a Board Member of Medivir. Yilmaz Mahshid joins Medivir from his recent 9 Jul 2015 Uli Hacksell has over 20 years of international management experience from both large pharmaceutical and biotech companies. He was the CEO Uli Hacksell, vd Medivir.

Uli Hacksell är ett känt ansikte för många farmaceuter. Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir och har under 90-talet innehaft seniora positioner vid Astra, numera Astra Zeneca.
Besiktning fordon 50 år

11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $83,600 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell CERC stock SEC Form 4 insiders trading Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Uli Hacksell 1 , Ethan S Burstein, Krista McFarland, Roger G Mills, Hilde Williams. Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Uli Hacksell, Ph.D. Chairman of the Board Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018.

Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016. Uli Hacksell har över 20 års internationell erfarenhet från ledande positioner inom FoU på stora läkemedels- och bioteknikföretag, bl.a.
Uppstoppade djur engelska

hopliter
dan hasson clothier
salutogent
grillska gymnasiet sundbyberg lunch
saker man kan gora av tra
renseriet englandsvej
kol förbränning formel

Uli Hacksell, vd Medivir. Av Nyheter Direkt den 27 november 2019 18:06. Det innebär att Medivir nu har fyra pågående kliniska studier inom cancer; två i fas 1

Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.